Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
329.00    0.00 (0.00%)
Bid:
322.00
Ask:
336.00
Spread: 14.00 (4.348%)
Market Cap: £41.75m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

15 Jul 2016 07:00

RNS Number : 2623E
BrainJuicer Group PLC
15 July 2016
 

 

 

 

Press Release

15 July 2016

 

 

BrainJuicer Group PLC (AIM: BJU)

("BrainJuicer", or "the Company")

 

Six month Trading Update

 

BrainJuicer, the innovative international market research agency, today releases the following six month ("H1") trading update. The Company will announce its interim results for the six months to 30 June 2016 on 16 September 2016.

 

Top line growth during H1 was generally encouraging. Revenue increased by 13%, and by 9% in constant currencies, and gross profit (our main top-line performance indicator) grew by 15%, and 11% in constant currencies. Our largest market, the US, performed strongly, with gross profit rising by some 27%; gross profit in Continental Europe and Brazil also grew well, increasing by 30% and 22% respectively. Gross profit in our second largest market, the UK, declined by 2%, and in our China and Singapore region it also declined slightly by 5%.

 

Our Ad Testing and Brand Tracking services continued to grow strongly, with gross profit up 59% year on year. Much of this business is Ongoing in nature (as opposed to Ad Hoc), and builds on the "Fame, Feeling & Fluency" approach to brand building that we introduced last year.

 

After factoring in our new creative agency, System1, which was launched during H1 and, as anticipated, incurred costs of some £0.3m, BrainJuicer's operating profit increased by some 41% to around £1.7m. After adjusting for exceptional items (share based payments and also the one-off costs in H1 2015 relating to due diligence work and our Head Office move) normalized H1 pre-tax profit will be similar to the £1.7m reported in 2015.

 

BrainJuicer's financial position remains strong. At the end of June the Company had a cash balance of £5.2m (December 2015: £6.4m), after returning £2.2m to shareholders during H1 by way of dividends and share buy-backs.

The Company generates the majority of its annual profit in the second half of the year, and whilst our revenue visibility is, as ever, limited the Board believes that the Company is in a position to meet market expectations for the full year.

 

The decline in the value of sterling versus the US Dollar, the Euro and other leading currencies following the referendum on the UK's membership of the EU benefits the Company's non-UK profits reported in sterling. The results of our overseas businesses are translated into sterling using monthly average exchange rates. Beyond this, it is too early to say what the impact of the UK's exit from the EU on the market research budgets of our clients is likely to be.

 

This announcement contains inside information. The Company can be found at www.brainjuicer.com.

 

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0)20 7043 1000

 

John Kearon, Chief Executive Officer

 

James Geddes, Chief Financial Officer

 

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Henry Fitzgerald-O'Connor / Emma Gabriel

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSABRNWABAAR
Date   Source Headline
5th Sep 20197:00 amRNSGrant of Options
1st Aug 20197:00 amRNSResult of AGM
28th Jun 201912:30 pmRNSAnnual Report and Notice of AGM
12th Jun 20197:00 amRNSHolding(s) in Company
6th Jun 20197:00 amRNSDividend Declaration
6th Jun 20197:00 amRNSFinancial results to 31 March 2019
18th Apr 20197:00 amRNSGrant of Options
15th Apr 20197:00 amRNSTrading Update
19th Nov 20187:00 amRNSDirector/PDMR Shareholding
6th Nov 20188:24 amRNSHolding(s) in Company
6th Nov 20187:00 amRNSPDMR Shareholding
2nd Nov 20184:08 pmRNSDividend Declaration
2nd Nov 20187:00 amRNSInterim Results
15th Oct 20187:00 amRNSTrading Update
2nd Oct 20189:09 amRNSHolding(s) in Company
28th Sep 201810:15 amRNSHolding(s) in Company
21st Sep 201811:56 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSAd Ratings and Trading Update
31st Aug 20185:02 pmRNSTotal Voting Rights
20th Aug 20187:00 amRNSHolding(s) in Company
17th Aug 20182:58 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSExercise of Options
26th Jul 20187:00 amRNSDirectorate Change
25th Jul 201812:04 pmRNSResult of AGM
24th Jul 20187:00 amRNSBoard Changes
10th Jul 20189:12 amRNSHolding(s) in Company
9th Jul 201811:31 amRNSHolding(s) in Company
2nd Jul 20183:50 pmRNSAnnual Report and Notice of AGM
28th Jun 20185:57 pmRNSHolding(s) in Company
12th Jun 20187:00 amRNSExercise of Options
11th Jun 20187:00 amRNSBoard Change
5th Jun 20184:31 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSDirector/PDMR Shareholding
4th Jun 20183:10 pmRNSDividend Declaration
1st Jun 20187:00 amRNSFinancial results to 31 March 2018
23rd May 20188:26 amRNSHolding(s) in Company
27th Apr 20184:30 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSTrading Update
9th Mar 20183:30 pmRNSTransaction in Own Shares
9th Mar 20187:00 amRNSExercise of Options and Buyback of Option Shares
8th Jan 20187:00 amRNSTrading Update
28th Nov 201711:52 amRNSHolding(s) in Company
27th Nov 20179:48 amRNSHolding(s) in Company
17th Nov 20177:00 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSInterim Results
16th Oct 20177:00 amRNSTrading Update
2nd Oct 20174:26 pmRNSHolding(s) in Company
12th Sep 20172:31 pmRNSHolding(s) in Company
21st Aug 20175:49 pmRNSHolding(s) in Company
21st Aug 20177:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.